Trans-coronary transplantation may be an optimal route in cellular cardiomyoplasty with stem cells

Medical Hypotheses

Volumn 69, Issue 6, 2007, Pages 1212-1218

  Li, Zhi Zhong ^a   Bai, Shu Gong ^a   Huang, Ji ^a,b   Qian, Hai Yan ^c  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

^c FUWAI HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CARDIOMYOPLASTY; HEART CATHETERIZATION; HEART INFARCTION; HUMAN; NONHUMAN; PRIORITY JOURNAL; RISK ASSESSMENT; STEM CELL TRANSPLANTATION;

ANIMALS; CARDIOMYOPLASTY; CATHETERIZATION; CLINICAL TRIALS AS TOPIC; HUMANS; MODELS, THEORETICAL; MYOCARDIAL INFARCTION; MYOCARDIAL ISCHEMIA; STEM CELL TRANSPLANTATION; STEM CELLS;

ANIMALIA;

EID: 35548966685     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2007.04.013     Document Type: Article

References (50)

1. Cohn J.N., Bristow M.R., Chien K.R., et al. Report of the National Heart, Lung, and Blood Institute special emphasis panel on heart failure research. Circulation 95 (1997) 766-770
2. Beltrami A.P., Urbanek K., Kajstura J., et al. Evidence that human cardiac myocytes divide after myocardial infarction. N Engl J Med 344 (2001) 1750-1757
3. Nadal-Ginard B., Kajstura J., Leri A., and Anversa P. Myocyte death, growth, and regeneration in cardiac hypertrophy and failure. Circ Res 92 (2003) 139-150
4. Pittenger M.F., Mackay A.M., Beck S.C., et al. Multilineage potential of adult human mesenchymal stem cells. Science 284 (1999) 143-147
5. Krause D.S., Theise N.D., Collector M.I., et al. Multi-organ, multi-lineage engraftment by a single bone marrow-derived stem cell. Cell 105 (2001) 369-377
6. Jiang Y., Jahagirdar B.N., Reinhardt R.L., et al. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 418 (2002) 41-49
7. Orlic D., Kajstura J., Chimenti S., et al. Bone marrow cells regenerate infarcted myocardium. Nature 410 (2001) 701-705
8. Fernandez-Aviles F., San Roman J.A., Garcia-Frade J., et al. Experimental and clinical regenerative capability of human bone marrow cells after myocardial infarction. Circ Res 95 (2004) 742-748
9. Schuster M.D., Kocher A.A., Seki T., et al. Myocardial neovascularization by bone marrow angioblasts results in cardiomyocyte regeneration. Am J Physiol Heart Circ Physiol 287 (2004) H525-H532
10. Herreros J., Prosper F., Perez A., et al. Autologous intramyocardial injection of cultured skeletal muscle-derived stem cells in patients with non-acute myocardial infarction. Eur Heart J 24 (2003) 2012-2020
11. Stamm C., Westphal B., Kleine H.D., et al. Autologous bone-marrow stem-cell transplantation for myocardial regeneration. Lancet 361 (2003) 45-46
12. Tse H.F., Kwong Y.L., Chan J.K., Lo G., Ho C.L., and Lau C.P. Angiogenesis in ischaemic myocardium by intramyocardial autologous bone marrow mononuclear cell implantation. Lancet 361 (2003) 47-49
13. Perin E.C., Dohmann H.F., Borojevic R., et al. Improved exercise capacity and ischemia 6 and 12 months after transendocardial injection of autologous bone marrow mononuclear cells for ischemic cardiomyopathy. Circulation 110 (2004) 213-218
14. Wollert K.C., Meyer G.P., Lotz J., et al. Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial. Lancet 364 (2004) 141-148
15. Ozbaran M., Omay S.B., Nalbantgil S., et al. Autologous peripheral stem cell transplantation in patients with congestive heart failure due to ischemic heart disease. Eur J Cardio-thoracic Surg 25 (2004) 342-351
16. Alvarez-Dolado M., Pardal R., Garcia-Verdugo J.M., et al. Fusion of bone-marrow-derived cells with Purkinje neurons, cardiomyocytes and hepatocytes. Nature 425 (2003) 968-973
17. Nygren J.M., Jovinge S., Breitbach M., et al. Bone marrow-derived hematopoietic cells generate cardiomyocytes at a low frequency through cell fusion, but not transdifferentiation. Nat Med 10 (2004) 494-501
18. Kocher A.A., Schuster M.D., Szabolcs M.J., et al. Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat Med 7 (2001) 430-436
19. Kamihata H., Matsubara H., Nishiue T., et al. Circulation 104 (2001) 1046-1052
20. Suzuki K., Murtuza B., Fukushima S., et al. Targeted cell delivery into infarcted rat hearts by retrograde intracoronary infusion: distribution, dynamics, and influence on cardiac function. Circulation 110 (2004) II225-II230
21. Kinnaird T., Stabile E., Burnett M.S., et al. Marrow-derived stromal cells express genes encoding a broad spectrum of arteriogenic cytokines and promote in vitro and in vivo arteriogenesis through paracrine mechanisms. Circ Res 94 (2004) 678-685
22. Gnecchi M., He H., Liang O.D., et al. Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cells. Nat Med 11 (2005) 367-368
23. Amado L.C., Saliaris A.P., Schuleri K.H., et al. Cardiac repair with intramyocardial injection of allogeneic mesenchymal stem cells after myocardial infarction. Proc Natl Acad Sci USA 102 (2005) 11474-11479
24. Strauer B.E., Brehm M., Zeus T., et al. Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans. Circulation 106 (2002) 1913-1918
25. Hofmann M., Wollert K.C., Meyer G.P., et al. Monitoring of bone marrow cell homing into the infarcted human myocardium. Circulation 111 (2005) 2198-2202
26. Qian HY, Yang YJ, Huang J, et al. Intracoronary delivery of autologous bone marrow mononuclear cells radiolabeled by 18F-fluoro-deoxy-glucose: tissue distribution and impact on post-infarct swine hearts. J Cell Biochem 2007 [Epub ahead of print].
27. Vulliet P.R., Greeley M., Halloran S.M., MacDonald K.A., and Kittleson M.D. Intra-coronary arterial injection of mesenchymal stromal cells and microinfarction in dogs. Lancet 363 (2004) 783-784
28. Van derheyden M., Mansour S., and Bartunek J. Accelerated atherosclerosis following intracoronary haematopoietic stem cell administration. Heart 91 (2005) 448
29. Kang H.J., Kim H.S., Zhang S.Y., et al. Effects of intracoronary infusion of peripheral blood stem-cells mobilised with granulocyte-colony stimulating factor on left ventricular systolic function and restenosis after coronary stenting in myocardial infarction: the MAGIC cell randomised clinical trial. Lancet 363 (2004) 751-756
30. Steinwender C., Hofmann R., Kammler J., et al. Effects of peripheral blood stem cell mobilization with granulocyte-colony stimulating factor and their transcoronary transplantation after primary stent implantation for acute myocardial infarction. Am Heart J 151 (2006) 1296e7-1296e13
31. Inoue T., Sata M., Hikichi Y., et al. Mobilization of CD34-positive bone marrow-derived cells after coronary stent implantation: impact on restenosis. Circulation 115 (2007) 553-561
32. Katritsis D.G., Sotiropoulou P., Giazitzoglou E., Karvouni E., and Papamichail M. Electrophysiological effects of intracoronary transplantation of autologous mesenchymal and endothelial progenitor cells. Europace 9 (2007) 167-171
33. Schueller PO, Meyer C, Brehm M, Wernet P, Schannwell CM, Strauer BE. Intracoronary autologous bone marrow cell transplantation beneficially modulates heart rate variability. Int J Cardiol 2006 [Epub ahead of print].
34. Gao L.R., Wang Z.G., Zhu Z.M., et al. Effect of intracoronary transplantation of autologous bone marrow-derived mononuclear cells on outcomes of patients with refractory chronic heart failure secondary to ischemic cardiomyopathy. Am J Cardiol 98 (2006) 597-602
35. Erbs S., Linke A., Adams V., et al. Transplantation of blood-derived progenitor cells after recanalization of chronic coronary artery occlusion: first randomized and placebo-controlled study. Circ Res 97 (2005) 756-762
36. Aviles F.F., San Roman J.A., Garcia Frade J., et al. Intracoronary stem cell transplantation in acute myocardial infarction. Rev Esp Cardiol 57 (2004) 201-208
37. Boyle A.J., Whitbourn R., Schlicht S., et al. Intra-coronary high-dose CD34+ stem cells in patients with chronic ischemic heart disease: a 12-month follow-up. Int J Cardiol 109 (2006) 21-27
38. Chen S.L., Fang W.W., Ye F., et al. Effect on left ventricular function of intracoronary transplantation of autologous bone marrow mesenchymal stem cell in patients with acute myocardial infarction. Am J Cardiol 94 (2004) 92-95
39. Hofmann M., Wollert K.C., Meyer G.P., et al. Monitoring of bone marrow cell homing into the infarcted human myocardium. Circulation 111 (2005) 2198-2202
40. Britten M.B., Abolmaali N.D., Assmus B., et al. Infarct remodeling after intracoronary progenitor cell treatment in patients with acute myocardial infarction (TOPCARE-AMI): mechanistic insights from serial contrast-enhanced magnetic resonance imaging. Circulation 108 (2003) 2212-2218
41. Schachinger V., Assmus B., Britten M.B., et al. Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction final one-year results of the TOPCARE-AMI trial. J Am Coll Cardiol 44 (2004) 1690-1699
42. Blatt A., Cotter G., Leitman M., et al. Intracoronary administration of autologous bone marrow mononuclear cells after induction of short ischemia is safe and may improve hibernation and ischemia in patients with ischemic cardiomyopathy. Am Heart J 150 (2005) 986e1-986e7
43. Strauer B.E., Brehm M., Zeus T., et al. Regeneration of human infarcted heart muscle by intracoronary autologous bone marrow cell transplantation in chronic coronary artery disease: the IACT study. J Am Coll Cardiol 46 (2005) 1651-1658
44. Li R.K., Mickle D.A., Weisel R.D., Rao V., and Jia Z.Q. Optimal time for cardiomyocyte transplantation to maximize myocardial function after left ventricular injury. Ann Thorac Surg 72 (2001) 1957-1963
45. Janssens S., Dubois C., Bogaert J., et al. Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: double-blind, randomised controlled trial. Lancet 367 (2006) 113-121
46. Schachinger V. Intracoronary infusion of bone marrow-derived progenitor cells in acute myocardial infarction: a randomized, double-blind, placebo-controlled multicenter trial [REPAIR-AMI]. Late-breaking clinical trial reported at the plenary scientific sessions of the American Heart Association Meeting, Dallas, Nov 13, 2005.
47. Ge J., Li Y., Qian J., et al. Efficacy of emergent transcatheter transplantation of stem cells for treatment of acute myocardial infarction (TCT-STAMI). Heart 92 (2006) 1764-1767
48. Lunde K., Solheim S., Aakhus S., et al. Autologous stem cell transplantation in acute myocardial infarction: the ASTAMI randomized controlled trial-intracoronary transplantation of autologous mononuclear bone marrow cells, study design and safety aspects. Scand Cardiovasc J 39 (2005) 150-158
49. Schachinger V., Erbs S., Elsasser A., et al. Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. N Engl J Med 355 (2006) 1210-1221
50. Agbulut O., Menot M.L., Li Z.L., et al. Temporal patterns of bone marrow cell differentiation following transplantation in doxorubicin-induced cardiomyopathy. Cardiovasc Res 58 (2003) 451-459